Budecort Inhaler
Budecort Inhaler

35.56
For patients managing respiratory conditions, this generic medicine modulates inflammatory responses. Reduces swelling within tight airways to assist with easier breathing and consistent lung function over time.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Budesonide
Reference Brand
Budesonide
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Inhaler
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Glucocorticoid
Pharmacological Class
Corticosteroid Inhaler
Manufacturer Description
Intended to relieve airway swelling to support ongoing respiration and mitigate hyperreactive bronchial flares.
Mechanism of Action
Suppresses mucosal inflammation and reduces airway wall thickness by inhibiting local cytokine and prostaglandin synthesis.
Route of Administration
Inhalation
Onset Time
1–2 weeks
Duration
12 hours
Contraindications
Status asthmaticus, Hypersensitivity to budesonide
Severe Adverse Events
Paradoxical bronchospasm — requires immediate medical attention, Adrenal insufficiency — requires immediate medical attention
Common Side Effects
Throat irritation, Cough, Hoarseness
Uncommon Side Effects
Oral thrush, Headache, Sinusitis
Drug Interactions
Ketoconazole, Ritonavir
Pregnancy Safety Warnings
TGA Category B: Clinically safe based on large epidemiological studies. Breastfeeding: Compatible.
Age Restrictions
Approved for children and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Budecort Inhaler is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Thyroid Health AU - Levothyroxine Hypothyroid T4 Tablet